These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35458590)

  • 61. Modulation of tamoxifen sensitivity by antisense Bcl-2 and trastuzumab in breast carcinoma cells.
    Kim R; Tanabe K; Emi M; Uchida Y; Toge T
    Cancer; 2005 May; 103(10):2199-207. PubMed ID: 15830342
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Knockdown of CD24 inhibits proliferation, invasion and sensitizes breast cancer MCF-7 cells to tamoxifen in vitro.
    Ma ZL; Chen YP; Song JL; Wang YQ
    Eur Rev Med Pharmacol Sci; 2015 Jul; 19(13):2394-9. PubMed ID: 26214774
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prosopis juliflora (Sw.) DC phytochemicals induce apoptosis and inhibit cell proliferation signaling pathways, EMT, migration, invasion, angiogenesis and stem cell markers in melanoma cell lines.
    Choudhari J; Nimma R; Nimal SK; Totakura Venkata SK; Kundu GC; Gacche RN
    J Ethnopharmacol; 2023 Aug; 312():116472. PubMed ID: 37062530
    [TBL] [Abstract][Full Text] [Related]  

  • 64. BreastDefend enhances effect of tamoxifen in estrogen receptor-positive human breast cancer in vitro and in vivo.
    Cheng S; Castillo V; Welty M; Alvarado M; Eliaz I; Temm CJ; Sandusky GE; Sliva D
    BMC Complement Altern Med; 2017 Feb; 17(1):115. PubMed ID: 28209156
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Anticancer effect of acid ceramidase inhibitor ceranib-2 in human breast cancer cell lines MCF-7, MDA MB-231 by the activation of SAPK/JNK, p38 MAPK apoptotic pathways, inhibition of the Akt pathway, downregulation of ERα.
    Vethakanraj HS; Sesurajan BP; Padmanaban VP; Jayaprakasam M; Murali S; Sekar AK
    Anticancer Drugs; 2018 Jan; 29(1):50-60. PubMed ID: 29023248
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells.
    De Vincenzo R; Scambia G; Benedetti Panici P; Fattorossi A; Bonanno G; Ferlini C; Isola G; Pernisco S; Mancuso S
    Int J Cancer; 1996 Nov; 68(3):340-8. PubMed ID: 8903476
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Triaryl dicationic DNA minor-groove binders with antioxidant activity display cytotoxicity and induce apoptosis in breast cancer.
    Nafie MS; Arafa K; Sedky NK; Alakhdar AA; Arafa RK
    Chem Biol Interact; 2020 Jun; 324():109087. PubMed ID: 32294457
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Combined antitumor activity of 7-hydroxystaurosporine (UCN-01) and tamoxifen against human breast carcinoma in vitro and in vivo.
    Koh J; Kubota T; Koyama T; Migita T; Hashimoto M; Hosoda Y; Kitajima M
    Breast Cancer; 2003; 10(3):260-7. PubMed ID: 12955040
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of Evening Primrose (
    Paciorek-Sadowska J; Borowicz M; Isbrandt M
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445654
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Apoptotic effect of noscapine in breast cancer cell lines.
    Quisbert-Valenzuela EO; Calaf GM
    Int J Oncol; 2016 Jun; 48(6):2666-74. PubMed ID: 27081867
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Anti-Cancer Effects of Epigenetics Drugs Scriptaid and Zebularine in Human Breast Adenocarcinoma Cells.
    Yap ZH; Kong WY; Azeez AR; Fang CM; Ngai SC
    Anticancer Agents Med Chem; 2022; 22(8):1582-1591. PubMed ID: 34102995
    [TBL] [Abstract][Full Text] [Related]  

  • 72. 5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of tamoxifen in breast cancer cells.
    Segala G; de Medina P; Iuliano L; Zerbinati C; Paillasse MR; Noguer E; Dalenc F; Payré B; Jordan VC; Record M; Silvente-Poirot S; Poirot M
    Biochem Pharmacol; 2013 Jul; 86(1):175-89. PubMed ID: 23500540
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cell Cycle Modulation of MCF-7 and MDA-MB-231 by a Sub- Fraction of Strobilanthes crispus and its Combination with Tamoxifen.
    Yaacob NS; Nik Mohamed Kamal NN; Wong KK; Norazmi MN
    Asian Pac J Cancer Prev; 2015; 16(18):8135-40. PubMed ID: 26745050
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oridonin synergistically enhances the anti-tumor efficacy of doxorubicin against aggressive breast cancer via pro-apoptotic and anti-angiogenic effects.
    Li J; Wu Y; Wang D; Zou L; Fu C; Zhang J; Leung GP
    Pharmacol Res; 2019 Aug; 146():104313. PubMed ID: 31202781
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines.
    Kim J; Lee J; Jang SY; Kim C; Choi Y; Kim A
    Oncol Rep; 2016 May; 35(5):2553-60. PubMed ID: 26986571
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators.
    Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM
    Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cytotoxicity of eupatorin in MCF-7 and MDA-MB-231 human breast cancer cells via cell cycle arrest, anti-angiogenesis and induction of apoptosis.
    Razak NA; Abu N; Ho WY; Zamberi NR; Tan SW; Alitheen NB; Long K; Yeap SK
    Sci Rep; 2019 Feb; 9(1):1514. PubMed ID: 30728391
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In Vitro and In Vivo Effects of Jia-Wei-Xiao-Yao-San in Human Breast Cancer MCF-7 Cells Treated With Tamoxifen.
    Chen JL; Chang CJ; Wang JY; Wen CS; Tseng LM; Chang WC; Noomhorm N; Liu HJ; Chen WS; Chiu JH; Shyr YM
    Integr Cancer Ther; 2014 May; 13(3):226-39. PubMed ID: 24525674
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A naringenin-tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells.
    Hatkevich T; Ramos J; Santos-Sanchez I; Patel YM
    Exp Cell Res; 2014 Oct; 327(2):331-9. PubMed ID: 24881818
    [TBL] [Abstract][Full Text] [Related]  

  • 80. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
    Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
    Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.